You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


Advertisement

ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | RSS | Access Rights | Sign In


  Vol. 50 No. 2, February 1993 TABLE OF CONTENTS
  Online Only
 •  Online First Table of
Contents
  ORIGINAL CONTRIBUTIONS
 •Online Features
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (430)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Delicious Add to Digg Add to Facebook Add to Reddit Add to Technorati Add to Twitter What's this?

A Clinicopathologic Study of 100 Cases of Parkinson's Disease

Andrew J. Hughes, FRACP; Susan E. Daniel, MD; Siobhan Blankson; Andrew J. Lees, MD

Arch Neurol. 1993;50(2):140-148.


Abstract



• The clinical details of 100 cases of histologically confirmed Parkinson's disease were examined and correlated with pathologic findings. Age at disease onset (mean, 62.4 years), disease duration (mean, 13.1 years), and age at death (mean, 75.5 years) were similar to those in previous smaller series. Asymmetric, tremulous onset was most common, although 23% of patients had no rest tremor. Motor fluctuations and dyskinesias occurred in 60% of levodopa-treated patients. All patients had clinical parkinsonism; however, 12 had atypical clinical features of Parkinson's disease, including severe early dementia, fluctuating confusional states, no response to levodopa, and early marked autonomic disturbance. Neuropathologic examination found coexistent Alzheimer-type change in 17 cases and striatal abnormality—mainly vascular—in 34 cases. Cortical Lewy bodies were present in all cases, but only four satisfied proposed criteria for diffuse Lewy body disease. Dementia occurred in 44% of cases; 29% had Alzheimer's disease, 10% had numerous cortical Lewy bodies, and 6% had a possible vascular cause; in 55% no definite pathologic cause was found. Nigral cell loss correlated with disease duration and severity. Although the general pattern of disease conformed to traditional descriptions, the findings broaden the present clinical and pathologic spectrum of Parkinson's disease.



Author Affiliations



From the Department of Neurology, The Middlesex Hospital, London, England (Drs Hughes and Lees); and Parkinson's Disease Society Brain Bank, Institute of Neurology, London (Drs Hughes, Daniel, and Lees and Ms Blankson).


Footnotes



Accepted for publication July 9, 1992.

Reprint requests to Parkinson's Disease Society Brain Bank, Institute of Neurology, 1 Wakefield St, London WC1 N 1 PJ, England (Dr Lees).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Delicious Delicious   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

What Genetics Tells us About the Causes and Mechanisms of Parkinson's Disease
Corti et al.
Physiol. Rev. 2011;91:1161-1218.
ABSTRACT | FULL TEXT  

A practical guide to the differential diagnosis of tremor
Alty and Kempster
Postgrad. Med. J. 2011;87:623-629.
ABSTRACT | FULL TEXT  

Deep Brain Stimulation in Benign Tremulous Parkinsonism
Savica et al.
Arch Neurol 2011;68:1033-1036.
ABSTRACT | FULL TEXT  

APOE Alleles in Parkinson Disease and Their Relationship to Cognitive Decline: A Population-based, Longitudinal Study
Kurz et al.
J Geriatr Psychiatry Neurol 2009;22:166-170.
ABSTRACT  

Simple Ratio Analysis of 18F-Fluorodopa Uptake in Striatal Subregions Separates Patients with Early Parkinson Disease from Healthy Controls
Jokinen et al.
JNM 2009;50:893-899.
ABSTRACT | FULL TEXT  

A new perspective on brain derived neurotrophin factor polymorphism in L-dopa induced dyskinesia
Moreau and Destee
J. Neurol. Neurosurg. Psychiatry 2009;80:129-129.
FULL TEXT  

Chapter 40 Movement disorders
Fletcher
Brain's Diseases of the Nervous System 2009;12:med-9780198569381-chapter-med-9780198569381-chapter.
ABSTRACT | FULL TEXT  

Amyloid load in Parkinson's disease dementia and Lewy body dementia measured with [11C]PIB positron emission tomography
Edison et al.
J. Neurol. Neurosurg. Psychiatry 2008;79:1331-1338.
ABSTRACT | FULL TEXT  

Imaging amyloid deposition in Lewy body diseases
Gomperts et al.
Neurology 2008;71:903-910.
ABSTRACT | FULL TEXT  

Parkinson's disease: clinical features and diagnosis
Jankovic
J. Neurol. Neurosurg. Psychiatry 2008;79:368-376.
ABSTRACT | FULL TEXT  

RHINORRHEA AND OLFACTION IN PARKINSON DISEASE
Friedman et al.
Neurology 2008;70:487-489.
FULL TEXT  

Safety and tolerability of adjunctive tolcapone treatment in patients with early Parkinson's disease
Lees et al.
J. Neurol. Neurosurg. Psychiatry 2007;78:944-948.
ABSTRACT | FULL TEXT  

In dementia with Lewy bodies, Braak stage determines phenotype, not Lewy body distribution
Weisman et al.
Neurology 2007;69:356-359.
ABSTRACT | FULL TEXT  

Clinical phenotype of Parkinson disease dementia.
Galvin et al.
Neurology 2006;67:1605-1611.
ABSTRACT | FULL TEXT  

Locomotor Training in People With Parkinson Disease
Morris
ptjournal 2006;86:1426-1435.
ABSTRACT | FULL TEXT  

RTP801 Is Elevated in Parkinson Brain Substantia Nigral Neurons and Mediates Death in Cellular Models of Parkinson's Disease by a Mechanism Involving Mammalian Target of Rapamycin Inactivation
Malagelada et al.
J. Neurosci. 2006;26:9996-10005.
ABSTRACT | FULL TEXT  

Is it Parkinson's disease, and if not, what is it?
Taylor and Counsell
PN 2006;6:154-165.
FULL TEXT  

Analysis of High-Frequency Electroencephalographic-Electromyographic Coherence Elicited by Speech and Oral Nonspeech Tasks in Parkinson's Disease
Caviness et al.
JSLHR 2006;49:424-438.
ABSTRACT | FULL TEXT  

Benign tremulous parkinsonism.
Josephs et al.
Arch Neurol 2006;63:354-357.
ABSTRACT | FULL TEXT  

Parkinson disease, brain volumes, and subthalamic nucleus stimulation
Bonneville et al.
Neurology 2005;64:1598-1604.
ABSTRACT | FULL TEXT  

Cognitive status correlates with neuropathologic stage in Parkinson disease
Braak et al.
Neurology 2005;64:1404-1410.
ABSTRACT | FULL TEXT  

Heterogeneity of Parkinson's disease in the early clinical stages using a data driven approach
Lewis et al.
J. Neurol. Neurosurg. Psychiatry 2005;76:343-348.
ABSTRACT | FULL TEXT  

Involvement of the Basal Ganglia in Refractory Epilepsy: An 18F-Fluoro-L-DOPA PET Study Using 2 Methods of Analysis
Bouilleret et al.
JNM 2005;46:540-547.
ABSTRACT | FULL TEXT  

Long duration asymmetric postural tremor in the development of Parkinson's disease
Grosset and Lees
J. Neurol. Neurosurg. Psychiatry 2005;76:9-9.
FULL TEXT  

Cognitive Dysfunction in Parkinson's Disease: The Role of Frontostriatal Circuitry
Owen
Neuroscientist 2004;10:525-537.
ABSTRACT  

Olfactory function distinguishes vascular parkinsonism from Parkinson's disease
Katzenschlager et al.
J. Neurol. Neurosurg. Psychiatry 2004;75:1749-1752.
ABSTRACT | FULL TEXT  

Subthalamic nucleus deep brain stimulation in Parkinson disease patients over age 70 years
Russmann et al.
Neurology 2004;63:1952-1954.
ABSTRACT | FULL TEXT  

Hippocampal and prefrontal atrophy in patients with early non-demented Parkinson's disease is related to cognitive impairment
Bruck et al.
J. Neurol. Neurosurg. Psychiatry 2004;75:1467-1469.
ABSTRACT | FULL TEXT  

Sensitivity and Specificity of 99mTc-TRODAT-1 SPECT Imaging in Differentiating Patients with Idiopathic Parkinson's Disease from Healthy Subjects
Weng et al.
JNM 2004;45:393-401.
ABSTRACT | FULL TEXT  

The cognitive ability of an incident cohort of Parkinson's patients in the UK. The CamPaIGN study
Foltynie et al.
Brain 2004;127:550-560.
ABSTRACT | FULL TEXT  

Parkinson's disease: piecing together a genetic jigsaw
Dekker et al.
Brain 2003;126:1722-1733.
ABSTRACT | FULL TEXT  

Lewy body cortical involvement may not always predict dementia in Parkinson's disease
Colosimo et al.
J. Neurol. Neurosurg. Psychiatry 2003;74:852-856.
ABSTRACT | FULL TEXT  

Occipital hypoperfusion in Parkinson's disease without dementia: correlation to impaired cortical visual processing
Abe et al.
J. Neurol. Neurosurg. Psychiatry 2003;74:419-422.
ABSTRACT | FULL TEXT  

Parkinson Disease With Old-Age Onset: A Comparative Study With Subjects With Middle-Age Onset
Diederich et al.
Arch Neurol 2003;60:529-533.
ABSTRACT | FULL TEXT  

Prevalence and Characteristics of Dementia in Parkinson Disease: An 8-Year Prospective Study
Aarsland et al.
Arch Neurol 2003;60:387-392.
ABSTRACT | FULL TEXT  

Autonomic nervous system testing may not distinguish multiple system atrophy from Parkinson's disease
Riley and Chelimsky
J. Neurol. Neurosurg. Psychiatry 2003;74:56-60.
ABSTRACT | FULL TEXT  

Parkinson's disease and anaesthesia
Nicholson et al.
Br J Anaesth 2002;89:904-916.
ABSTRACT | FULL TEXT  

Progression of gait disorder and rigidity and risk of death in older persons
Wilson et al.
Neurology 2002;58:1815-1819.
ABSTRACT | FULL TEXT  

Donepezil for cognitive impairment in Parkinson's disease: a randomised controlled study
Aarsland et al.
J. Neurol. Neurosurg. Psychiatry 2002;72:708-712.
ABSTRACT | FULL TEXT  

Molecular Findings in Familial Parkinson Disease in Spain
Hoenicka et al.
Arch Neurol 2002;59:966-970.
ABSTRACT | FULL TEXT  

The accuracy of diagnosis of parkinsonian syndromes in a specialist movement disorder service
Hughes et al.
Brain 2002;125:861-870.
ABSTRACT | FULL TEXT  

Dopaminergic Function and Dopamine Transporter Binding Assessed With Positron Emission Tomography in Parkinson Disease
Ribeiro et al.
Arch Neurol 2002;59:580-586.
ABSTRACT | FULL TEXT  

Subthalamic DBS replaces levodopa in Parkinson's disease: Two-year follow-up
Vingerhoets et al.
Neurology 2002;58:396-401.
ABSTRACT | FULL TEXT  

Subcortical dementia
TURNER et al.
Br. J. Psychiatry 2002;180:148-151.
ABSTRACT | FULL TEXT  

Neuroimaging in Dementia with Lewy Bodies: Metabolism, Neurochemistry, and Morphology
Minoshima et al.
J Geriatr Psychiatry Neurol 2002;15:200-209.
ABSTRACT  

Dementia with Lewy Bodies: Neuropathology
Dickson
J Geriatr Psychiatry Neurol 2002;15:210-216.
ABSTRACT  

Parkinson Disease Neuropathology: Later-Developing Dementia and Loss of the Levodopa Response
Apaydin et al.
Arch Neurol 2002;59:102-112.
ABSTRACT | FULL TEXT  

Increased risk of sensorineural hearing loss and migraine in patients with a rare mitochondrial DNA variant 4336A>G in tRNAGln
Finnila et al.
J. Med. Genet. 2001;38:400-405.
FULL TEXT  

Dinapsoline: Characterization of a D1 Dopamine Receptor Agonist in a Rat Model of Parkinson's Disease
Gulwadi et al.
J. Pharmacol. Exp. Ther. 2001;296:338-344.
ABSTRACT | FULL TEXT  

Pathology of PD in monozygotic twins with a 20-year discordance interval
Dickson et al.
Neurology 2001;56:981-982.
FULL TEXT  

Risk of dementia in Parkinson's disease: A community-based, prospective study
Aarsland et al.
Neurology 2001;56:730-736.
ABSTRACT | FULL TEXT  

Cardiac Sympathetic Denervation in Parkinson Disease
Goldstein et al.
ANN INTERN MED 2000;133:338-347.
ABSTRACT | FULL TEXT  

Alpha-synuclein cortical Lewy bodies correlate with dementia in Parkinson's disease
Hurtig et al.
Neurology 2000;54:1916-1921.
ABSTRACT | FULL TEXT  

What clinical features are most useful to distinguish definite multiple system atrophy from Parkinson's disease?
Wenning et al.
J. Neurol. Neurosurg. Psychiatry 2000;68:434-440.
ABSTRACT | FULL TEXT  

The Evolution of Diagnosis in Early Parkinson Disease
Jankovic et al.
Arch Neurol 2000;57:369-372.
ABSTRACT | FULL TEXT  

Cholinergic dysfunction in diseases with Lewy bodies
Tiraboschi et al.
Neurology 2000;54:407-407.
ABSTRACT | FULL TEXT  

Clinicopathologic correlates in temporal cortex in dementia with Lewy bodies
Gomez-Isla et al.
Neurology 1999;53:2003-2003.
ABSTRACT | FULL TEXT  

The tau gene A0 allele and progressive supranuclear palsy
Hoenicka et al.
Neurology 1999;53:1219-1219.
ABSTRACT | FULL TEXT  

Clinical and quantitative pathologic correlates of dementia with Lewy bodies
Gomez-Tortosa et al.
Neurology 1999;53:1284-1284.
ABSTRACT | FULL TEXT  

Progression of Parkinsonian Signs in Parkinson Disease
Louis et al.
Arch Neurol 1999;56:334-337.
ABSTRACT | FULL TEXT  

Accuracy of the Clinical Diagnoses of Lewy Body Disease, Parkinson Disease, and Dementia With Lewy Bodies: A Clinicopathologic Study
Litvan et al.
Arch Neurol 1998;55:969-978.
ABSTRACT | FULL TEXT  

Frontal cortical synaptophysin in Lewy body diseases: relation to Alzheimer's disease and dementia
Hansen et al.
J. Neurol. Neurosurg. Psychiatry 1998;64:653-656.
ABSTRACT | FULL TEXT  

Diagnostic Validity of the Dementia Questionnaire for Alzheimer Disease
Ellis et al.
Arch Neurol 1998;55:360-365.
ABSTRACT | FULL TEXT  

Neuropsychological prediction of dementia in Parkinson's disease
Mahieux et al.
J. Neurol. Neurosurg. Psychiatry 1998;64:178-183.
ABSTRACT | FULL TEXT  

Neurological Signs and Frontal White Matter Lesions in Vascular Parkinsonism : A Clinicopathologic Study
Yamanouchi and Nagura
Stroke 1997;28:965-969.
ABSTRACT | FULL TEXT  

Are Patients With Parkinson's Disease More Likely to Have Periventricular Hyperintensities Develop?-Reply
Piccini et al.
Arch Neurol 1996;53:211-212.
ABSTRACT  

Factors Predictive of the Need for Levodopa Therapy in Early, Untreated Parkinson's Disease
McDermott et al.
Arch Neurol 1995;52:565-570.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | PHYSICIAN JOBS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1993 American Medical Association. All Rights Reserved.